Literature DB >> 11329457

Influence of patient age on Streptococcus pneumoniae serotypes causing invasive disease.

J Inostroza1, A M Vinet, G Retamal, P Lorca, G Ossa, R R Facklam, R U Sorensen.   

Abstract

All clinical S. pneumoniae specimens isolated from patients with invasive or sterile-site infections admitted to one regional general hospital in southern Chile were collected during a 5-year period (February 1994 to September 1999). A total of 247 strains belonging to 50 serotypes were isolated in this survey: 69 in patients under 5 years of age, 129 in patients 5 to 64 years old, and 49 from patients 65 years and older. Eight serotypes were identified in all age groups, while all other serotypes were found exclusively in one age group or in patients over 4 years of age. Serotype 3 was never found in patients under 5 years old, and serotype 14 was not found in patients >64 years of age. There was no difference in the serotypes causing infection in each one of the 5 years of the survey. Our results suggest that both bacterial virulence factors and host factors play an important role in the selection of S. pneumoniae serotypes causing invasive infection. Possible host factors include age-related differences in the immune response. Comparative studies with other areas of the world may help to further understanding of our observations in southern Chile.

Entities:  

Mesh:

Year:  2001        PMID: 11329457      PMCID: PMC96100          DOI: 10.1128/CDLI.8.3.556-559.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

1.  Pneumococcal disease among children in a rural area of west Africa.

Authors:  T J O'Dempsey; T F McArdle; N Lloyd-Evans; I Baldeh; B E Lawrence; O Secka; B Greenwood
Journal:  Pediatr Infect Dis J       Date:  1996-05       Impact factor: 2.129

2.  Pneumococci causing invasive disease in New Zealand, 1987-94: serogroup and serotype coverage and antibiotic resistances.

Authors:  D R Martin; M S Brett
Journal:  N Z Med J       Date:  1996-08-09

3.  Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.

Authors:  N S Shahid; M C Steinhoff; S S Hoque; T Begum; C Thompson; G R Siber
Journal:  Lancet       Date:  1995-11-11       Impact factor: 79.321

4.  Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centers.

Authors:  D J Boken; S A Chartrand; E S Moland; R V Goering
Journal:  Pediatr Infect Dis J       Date:  1996-08       Impact factor: 2.129

Review 5.  Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.

Authors:  I R Friedland; G H McCracken
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

6.  Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand.

Authors:  L Voss; D Lennon; K Okesene-Gafa; S Ameratunga; D Martin
Journal:  Pediatr Infect Dis J       Date:  1994-10       Impact factor: 2.129

7.  Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management.

Authors:  S L Block; C J Harrison; J A Hedrick; R D Tyler; R A Smith; E Keegan; S A Chartrand
Journal:  Pediatr Infect Dis J       Date:  1995-09       Impact factor: 2.129

8.  Subtyping of common pediatric pneumococcal serotypes from invasive disease and pharyngeal carriage in Finland.

Authors:  A K Takala; J Vuopio-Varkila; E Tarkka; M Leinonen; J M Musser
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

9.  Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin.

Authors:  M K Zenni; S H Cheatham; J M Thompson; G W Reed; A B Batson; P S Palmer; K L Holland; K M Edwards
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406

10.  Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease.

Authors:  R W Steele; R Warrier; P J Unkel; B J Foch; R F Howes; S Shah; K Williams; S Moore; S J Jue
Journal:  J Pediatr       Date:  1996-04       Impact factor: 4.406

View more
  10 in total

1.  Host age modulates within-host parasite competition.

Authors:  Rony Izhar; Jarkko Routtu; Frida Ben-Ami
Journal:  Biol Lett       Date:  2015-05       Impact factor: 3.703

2.  Ten-year surveillance of pneumococcal infections in Temuco, Chile: implications for vaccination strategies.

Authors:  Jaime Inostroza; Vijna Illesca; Patricia Reydet; Ana Maria Vinet; Gonzalo Ossa; Sergio Muñoz; Terry Thompson; Ricardo U Sorensen
Journal:  Clin Vaccine Immunol       Date:  2007-03-28

3.  Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci.

Authors:  Q Chang; Z Zhong; A Lees; M Pekna; L Pirofski
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

4.  Analysis of Pneumonia Occurrence in Relation to Climate Change in Tanga, Tanzania.

Authors:  Samweli Faraja Miyayo; Patrick Opiyo Owili; Miriam Adoyo Muga; Tang-Huang Lin
Journal:  Int J Environ Res Public Health       Date:  2021-04-29       Impact factor: 3.390

5.  Retrospective review of invasive pediatric pneumococcal diseases in a military hospital in the southern region of Saudi Arabia.

Authors:  Mohammed Saeed Al Ayed; Ali Abdullah Hawan
Journal:  Ann Saudi Med       Date:  2011 Sep-Oct       Impact factor: 1.526

6.  Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types.

Authors:  Donald Inverarity; Karen Lamb; Mathew Diggle; Chris Robertson; David Greenhalgh; Tim J Mitchell; Andrew Smith; Johanna M C Jefferies; Stuart C Clarke; Jim McMenamin; Giles F S Edwards
Journal:  J Med Microbiol       Date:  2011-03-10       Impact factor: 2.472

7.  Neoglycoconjugate of Tetrasaccharide Representing One Repeating Unit of the Streptococcus pneumoniae Type 14 Capsular Polysaccharide Induces the Production of Opsonizing IgG1 Antibodies and Possesses the Highest Protective Activity As Compared to Hexa- and Octasaccharide Conjugates.

Authors:  Ekaterina A Kurbatova; Nelli K Akhmatova; Elina A Akhmatova; Nadezhda B Egorova; Natalya E Yastrebova; Elena V Sukhova; Dmitriy V Yashunsky; Yury E Tsvetkov; Marina L Gening; Nikolay E Nifantiev
Journal:  Front Immunol       Date:  2017-06-02       Impact factor: 7.561

8.  Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to Streptococcus pneumoniae Type 3 Capsular Polysaccharide.

Authors:  Ekaterina A Kurbatova; Nelli K Akhmatova; Anton E Zaytsev; Elina A Akhmatova; Nadezhda B Egorova; Natalya E Yastrebova; Elena V Sukhova; Dmitriy V Yashunsky; Yury E Tsvetkov; Nikolay E Nifantiev
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

9.  Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection.

Authors:  Nicholas J Croucher; Andrea M Mitchell; Katherine A Gould; Donald Inverarity; Lars Barquist; Theresa Feltwell; Maria C Fookes; Simon R Harris; Janina Dordel; Susannah J Salter; Sarah Browall; Helena Zemlickova; Julian Parkhill; Staffan Normark; Birgitta Henriques-Normark; Jason Hinds; Tim J Mitchell; Stephen D Bentley
Journal:  PLoS Genet       Date:  2013-10-10       Impact factor: 5.917

10.  Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against Streptococcus pneumoniae Serotype 14.

Authors:  Bruna M S Seco; Fei-Fei Xu; Andrea Grafmüller; Naresh Kottari; Claney L Pereira; Peter H Seeberger
Journal:  ACS Chem Biol       Date:  2020-09-08       Impact factor: 5.100

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.